CSRP2 and asthma: Upregulation of Csrp2 inhibits the PDGF-BB-induced transition of ASMCs to a synthetic/proliferative phenotype via modulation of the Yes-associated protein (YAP)/transcriptional coactivator with PDZ-binding motif (TAZ) signaling axis, thereby contributing to airway remodeling in asthma.